MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
MEK 抑制剂 PD-0325901 克服了对 CK2 抑制剂 CX-4945 的耐药性,并在头颈癌中表现出抗肿瘤活性
期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.10745
Bian Yansong, Han Jiawei, Kannabiran Vishnu, Mohan Suresh, Cheng Hui, Friedman Jay, Zhang Luo, VanWaes Carter, Chen Zhong